Ian Setliff
About Ian Setliff
Ian Setliff is a Senior Scientist in Computational Biology with expertise in antibody technology innovation and computational-experimental integration. He holds a PhD in Chemical & Physical Biology from Vanderbilt University and has experience in various roles within the biotechnology sector.
Work at Insmed
Ian Setliff serves as a Senior Scientist in Computational Biology at Insmed Incorporated. He has been with the company since 2021, contributing to the development of integrated computational-experimental technologies. His role involves collaboration with wet lab scientists to enhance research outcomes. Setliff's expertise in computational biology supports Insmed's initiatives in drug discovery and development.
Education and Expertise
Ian Setliff holds a Doctor of Philosophy (PhD) in Chemical & Physical Biology with a focus on Computational Immunology from Vanderbilt University, completed between 2015 and 2020. He also earned a Bachelor of Science (BSc) in Physics from The University of Edinburgh during a study abroad program in 2012, and a Bachelor of Science in Physics from the University of Richmond from 2009 to 2013. His educational background underpins his expertise in antibody technology innovation, protein sequence informatics, and machine learning applications in computational biology.
Background
Before joining Insmed, Ian Setliff gained valuable experience at Regeneron, where he worked as a Scientist in Molecular Profiling and later as a Senior Scientist in Molecular Profiling & Data Science. His tenure at Regeneron lasted from 2020 to 2021. Prior to that, he was a Graduate Research Assistant at Vanderbilt University Medical Center from 2015 to 2020, focusing on antibody discovery and single B cell screening.
Achievements
Ian Setliff has developed integrated computational-experimental technologies and has experience in single-cell and bulk -omics, target discovery, and clinical biomarker discovery. His work includes antibody-antigen structural analysis and computational methods development. Setliff specializes in immunogen design and protein engineering, contributing to advancements in antibody technology and BCR/TCR-seq.
Previous Work Experience
Before his scientific roles, Ian Setliff worked as an Analyst at Deloitte Consulting in Washington, D.C. from 2013 to 2015. This position provided him with foundational skills in data analysis and consulting, which he later applied in his scientific career. His diverse experience across consulting and scientific research enhances his capabilities in computational biology.